SEC Form 4 · accession 0001225208-15-013081
BOSTON SCIENTIFIC CORP · BSX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Maulik Nanavaty
Officer — SVP & Pres, Neuromodulation
Period of report
May 29, 2015
Accepted (ET)
Jun 1, 2015 · 4:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885725
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 29, 2015 | M | 50,466 | $7.16 | A | 185,000 | D | |
| Common StockF1 | May 29, 2015 | M | 21,092 | $6.28 | A | 206,092 | D | |
| Common StockF2,F1 | May 29, 2015 | S | 71,558 | $18.5204 | D | 134,534 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $6.28 | May 29, 2015 | M | 21,092 | D | — | Feb 27, 2022 | Common Stock | 21,092 | 7,031 | D |
| Stock Option (Right to Buy)F4 | $7.16 | May 29, 2015 | M | 50,466 | D | — | Feb 28, 2021 | Common Stock | 50,466 | 0 | D |
Explanation of responses
- F1Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.
- F2Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $18.51 to $18.55, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 27, 2013, the first anniversary of the date of grant.
- F4Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2012, the first anniversary of the date of grant.